Yoko Hosaka

687 citations
15 papers · 549 indexed · h-index 9
Topics
Osteoarthritis Treatment and Mechanisms (10 papers)Cancer, Hypoxia, and Metabolism (3 papers)Inflammatory mediators and NSAID effects (3 papers)
Partner nations
JapanUnited StatesMexico

In The Last Decade

Yoko Hosaka

14 papers receiving 542 citations

Peers

Yoko Hosaka
Comparison fields: 5 of 62
  • Rheumatology 342
  • Molecular Biology 221
  • Cancer Research 147
  • Pharmacology 125
  • Surgery 114
Replace Yoshifumi Mori with:
Yoshifumi Mori Japan
W. Bouaziz France
N. Ogata Japan
Koichiro Komiya Japan
Aiko Okada Japan
Mei Zhu United States
Zenjiro Maruyama Japan
Kristen M. Clements United Kingdom
Miyuki Chijiiwa Japan
Yoko Hosaka relative to Yoshifumi Mori Japan Yoshifumi Mori's profile →
Citations per field
00.5×1.5×2.1×
Yoshifumi Mori · 1×
Citations per year

Countries citing papers authored by Yoko Hosaka

Since Specialization
Citations

This map shows the geographic impact of Yoko Hosaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Hosaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Hosaka more than expected).

Fields of papers citing papers by Yoko Hosaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Hosaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Hosaka. The network helps show where Yoko Hosaka may publish in the future.

Co-authorship network of co-authors of Yoko Hosaka

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Hosaka. A scholar is included among the top collaborators of Yoko Hosaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Hosaka. Yoko Hosaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 3
3 7
4 81
5 18
6 83
7 23
8 1
9 4
10 160
11 74
12 34
13 34
14 2
15
Adrenocortical carcinoma: nuclear deoxyribonucleic acid ploidy studied by flow cytometry.
25

About Yoko Hosaka

Yoko Hosaka is a scholar working on Rheumatology, Cancer Research and Pharmacology, having authored 15 papers that have together received 549 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (10 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Rheumatology (342 citations), Cancer Research (147 citations) and Pharmacology (125 citations). Yoko Hosaka has collaborated with scholars based in Japan, United States and Mexico. Frequent co-authors include Taku Saito, Ung‐il Chung, Hiroshi Kawaguchi, Makoto Hirata, Hiroshi Kobayashi, Yuki Taniguchi, Haruhiko Akiyama, Atsushi Fukai, Shurei Sugita and Fumiko Yano. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026